A series of novel indole derivatives was designed and synthesized as inhibitors of fructose-1,6-bisphosphatase (FBPase). The most potent compound 14c was identified with an IC50 value of 0.10 μM by testing the inhibitory activity against recombinant human FBPase. The structure-activity relationships were investigated on the substitution at 4- and 5-position of the indole scaffold. The binding interactions of the title compounds at AMP binding site of FBPase were predicted using CDOCKER algorithm.
Keywords: Allosteric inhibitor; Diabetes; Fructose-1,6-bisphosphatase inhibitor; Indole derivative.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.